In human breast cancer, it is known that GJIC capacity is significantly decreased due to decreased expression of connexin proteins or failure of connexins to assemble into functional gap junctions, especially Cx26 and Cx43 [4,12,13,14]. The gene discussed is GJB2; the disease is breast carcinoma.